logo

Andrology Australia Advisory Board

An Advisory Board of key business, medical and community leaders guide the Director, CEO and Management group in their role to administer and monitor funding received for the Andrology Australia program and to ensure that the program objectives are met.

Mr David Crawford AO, Chairman (Vic.)

David is a former Partner and National Chairman of KPMG and is the current Chairman of Lend Lease Corporation Limited, Chairman of South32 and Chairman of Australian Airports Corporation Limited.

His past roles include a Director of BHP Billiton Limited, Chairman of Foster’s Group Limited, Chairman of National Foods Limited, Chairman of The Australian Ballet and Director of Westpac Banking Corporation.

David joined the Advisory Board and accepted the role of Chairman in April 2013.

Professor Robert I McLachlan, AM (Director)

Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research and is Deputy Director of Endocrinology at the Monash Medical Centre. He specialises in the area of male reproductive medicine and has made significant contributions to the research in endocrinology, infertility and andrology. He combines his academic career with active clinical practice as a consultant in these fields.

Rob is a consultant to the World Health Organisation (WHO) on male infertility regulation, is a former President of the Fertility Society of Australia, and former Secretary of the International Society of Andrology.

Rob was also named in the Queen’s Birthday 2016 Honours List as a recipient of the Member of the Order of Australia.

Professor David de Kretser, AC (Vic.)

David was instrumental in establishing Andrology Australia, serving as inaugural Director from 1999 to 2006. He returned to Monash University after his term as the 28th Governor of Victoria, a position he held until April 2011. He continues to serve on the Advisory Board and Management Group of Andrology Australia.

David has been a member of the Advisory Board since April 2011.

Ms Christine Enright (Vic.)

Chris Enright is a public health professional who works to address issues of health inequity, with a particular interest in innovating the approach men’s health for better individual outcomes.  Chris holds a Master of Health and Human Services Management and an MBA from Deakin University in Melbourne.  She has fifteen years experience in delivering major public health campaigns and drove Cancer Council Victoria’s men’s cancer prevention work for many years.

Chris has been based in the not for profit sector since 2005 and aligns with a social model of health and is currently a Director at North Western Melbourne Primary Health Network.  She has co-authored papers published in the Australian Journal of Public Health and Australian Family Physician.

Professor RA 'Frank' Gardiner AM (Qld.)

Robert Alexander ‘Frank’ Gardiner is a retired academic urologist, Faculty of Medicine, The University of Queensland. His academic base continues to be at the Centre for Clinical Research at the Royal Brisbane and Women’s Hospital. He is also an adjunct Professor at Edith Cowan University, Western Australia.

Frank has been a member of the Advisory Board since October 2005.

Dr Keith Gleeson (NSW.)

Dr Keith Gleeson is a Biripi / Daingutti man from the Mid North Coast of NSW. Dr Gleeson completed his HSC at Bombala High school in 1987 where he commenced his National Parks and Wildlife Career that spanned 9 years working in Victoria and NSW.  He completed a Bachelor of Applied Science (Parks and Heritage) in 1997 at Charles Sturt University.

In 2000 he commenced Bachelor of Medicine at the University of Newcastle and graduated in 2006. Having completed his residency years on the Central Coast Region of NSW, he then took up graduate training in General Practice and Fellowed in January 2014.

Dr Gleeson was the former Chair of the Indigenous General Practice Registrars Network and has served on numerous advisory boards such as: Hunter New England Area Health Advisory Committee, General Practice Rural Incentive Program and the National Aboriginal Faculty in the Royal Australian College of GP to name a few.

He has worked at Biripi Aboriginal Medical Corporation in Taree NSW for the last 7 years. In 2015 he co-published a monograph – titled “Engaging Aboriginal and Torres Strait Islander Communities in Prostrate Cancer” released by Prostrate Cancer Foundation of Australia.

Dr Gleeson has always maintained a strong Aboriginal Community focus and is a strong advocate of Aboriginal Community Controlled Health.

Professor David Handelsman, AO (NSW)

David is Foundation Director of the ANZAC Research Institute and Department of Andrology at Concord Hospital. He is Australia’s first Professor of Andrology (University of Sydney) and has long had interest in all aspects of male reproductive health, medicine and biology.

David has been a member of the Advisory Board since March 2002.

A/Professor Doug Lording (Vic.)

Doug is an endocrinologist and andrologist in private practice at Cabrini Hospital, Melbourne. Doug has a 35-year interest in sexual medicine and testosterone use in men, and is a national expert in erectile dysfunction.

Doug has been a member of the Advisory Board since March 2002.

Dr Kevin McGeechan (NSW.)

Dr McGeechan is a Senior Lecturer in Biostatistics at the School of Public Health, University of Sydney. In this position, Dr McGeechan has primary responsibility for teaching biostatistics in a number of foundation level and advanced level courses. He is also an active researcher in sexual and reproductive health and is currently involved in funded projects on the use of long acting reversible contraception and issues surrounding overdiagnosis. In addition to his academic position, Dr McGeechan acts as a consultant statistician for Family Planning NSW where he provides advice on study design, implementation and interpretation of results as well as statistical analysis. In 2013 he oversaw the production of the statistical report Reproductive and Sexual Health in Australia.

Mr Simon von Saldern, Chief Executive Officer

As CEO, Simon manages the Andrology Australia office and is responsible for overseeing the strategic direction of the program.

Simon’s diverse experience, most recently as General Manager of Development and Business Services at MOVE muscle, bone and joint health, ranges from strategy and planning to communication and stakeholder engagement, sales and marketing, financial, risk and compliance management.

Website by Essendon Creative